UnitedHealth Group stock reached a new 52-week high in June. JPMorgan, Bank of America, Leerink Partners, and Mizuho recently raised their price targets for the insurer. Analysts cite strong confidence in the company's performance and future outlook.
The upgrades follow UnitedHealth's April decision to increase its full-year 2026 earnings forecast. The company raised its adjusted earnings per share guidance to over $18.25. This figure is up from the $17.75 per share projection issued in January.
Price adjustments and effective medical cost management drove the guidance increase. These factors helped restore investor confidence following a period of volatility.